Workflow
Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations
Globenewswire· 2025-10-02 05:30
Press Release Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Additional pre-planned analysis of the NCX 470 Denali trial completed NCX 470 maintains robust intraocular pressure lowering at 6, 9 and 12 monthsOther analyses broadly in line with the trends seen for Mont BlancData presentations planned for upcoming ophthalmology conferences October 2, 2025 – release at 7:30 am CETSophia Antipolis, FranceNicox SA (Euronext Growth Paris ...
TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup
Globenewswire· 2025-10-02 05:30
TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup TomTom signs multi-year agreement to deliver traffic services to Hyundai AutoEver’s navigation for European vehicle lineup Hyundai AutoEver (HAE) and TomTom expand their partnership to equip vehicles across Europe with TomTom technology. TomTom Real-Time Traffic and Speed Camera Service to enhance HMG drivers’ in-dash navigation experience. AMSTERDAM, Oct. 02, 2025 (GLOBE NEWSWIRE) ...
Sampo plc’s share buybacks 1 October 2025
Globenewswire· 2025-10-02 05:30
Sampo plc, stock exchange release, 2 October 2025 at 8:30 am EEST Sampo plc’s share buybacks 1 October 2025 On 1 October 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows: Sampo plc’s share buybacksAggregated daily volume (in number of shares)Daily weighted average price of the purchased shares*Market (MIC Code) 8,5319.73AQEU 109,8269.74CEUX 27,4509.74TQEX 168,9809.75<td style="width:5cm ...
Technip Energies Announces Publication Date for Financial Results and Conference Call for the First Nine Months of 2025
Globenewswire· 2025-10-02 05:30
Technip Energies Announces Publication Date forFinancial Results and Conference Call for the First Nine Months of 2025 Technip Energies (PARIS:TE) will issue its financial results for the first nine months of 2025 on Thursday October 30, 2025 at 07:30 CET. The Company will host a results conference call on the same day at 13:00 CET. To participate in the conference call, please use one of the following telephone numbers and dial in approximately 10 minutes prior to the scheduled start time: FR: +33 1 70 9 ...
Grigeo Group AB subsidiary Grigeo Hygiene UAB acquires company Huchtemeier Papier GmbH
Globenewswire· 2025-10-02 05:00
Huchtemeier Papier GmbH Huchtemeier Papier GmbH On October 1, 2025 Grigeo Group AB subsidiary Grigeo Hygiene UAB has successfully completed the transaction and acquired 100% of the shares in the German company Huchtemeier Papier GmbH. Huchtemeier Papier GmbH supplies hygiene paper, napkins, and paper raw materials to wholesalers, specialized retailers, and industrial customers. In 2024, sales of this company reached €92 million, with EBITDA of €2.6 million. The transaction was financed by Grigeo Group A ...
South Star Provides Updates on Changes to Management and Board and Provides Operational Update
Globenewswire· 2025-10-02 03:03
- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - VANCOUVER, British Columbia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- South Star Battery Metals Corp. (“South Star” or the “Company”) (TSXV: STS) (OTCQB: STSBF), is pleased to provide an update to the recent changes in management and to the Board of Directors at the Company. Appointment of Tiago Cunha as Interim CEO, President and Director Further to the news release on September 11, 2025, Tiago Cunha has assumed the role of Interim C ...
Faraday Future Successfully Concludes FX Super One Co-Creation and Sales Event in Seattle
Globenewswire· 2025-10-02 02:58
Faraday Future Successfully Concludes FX Super One Co-Creation and Sales Event in Seattle Faraday Future Successfully Concludes FX Super One Co-Creation and Sales Event in Seattle, WA. Faraday Future Successfully Concludes FX Super One Co-Creation and Sales Event in Seattle Faraday Future Successfully Concludes FX Super One Co-Creation and Sales Event in Seattle, WA. LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (Nasdaq: FFAI) ("FF", "Faraday Future", or the ...
Reflex Advanced Materials Corporate Update
Globenewswire· 2025-10-02 00:29
VANCOUVER, British Columbia, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Reflex Advanced Materials Corp. (CSE:RFLX) (OTCQB:RFLXF) (FSE:HF2) (“Reflex” or the “Company”) provides the following updates in respect of a number of corporate and organizational matters. Management Transition Paul Gorman has resigned as CEO and Director of the Company. Reflex thanks Mr. Gorman for his contributions and wishes him well in his future endeavours. DJ Bowen, director of the Company, has assumed the role of interim CEO, while the C ...
DIH Holding US, Inc. Clarifies Previous Disclosure Regarding Additional Nasdaq Staff Determination Letter
Globenewswire· 2025-10-02 00:11
NORWELL, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- On September 18, 2025, DIH Holding US, Inc. (“DIH” or the “Company”) (NASDAQ:DHAI) issued a press release disclosing that it had received a notice on September 12, 2025, from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) that it had failed to regain compliance under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”), so this matter was an additional basis for delisting. The Company is clarifying that since it was ...
HUTCHMED Highlights Clinical Data to be Presented at the ESMO Congress 2025
Globenewswire· 2025-10-02 00:00
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 02, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology (“ESMO”) Congress 2025, taking place on October 17-21, 2025 in Berlin, Germany. Results from the FRUSICA-2 registration study of the fruquintinib and sintilimab combination as a second-line treatment for ...